Lifecore selected by Nirsum Laboratories to provide CDMO services

Lifecore (LFCR) Biomedical announced that it has been selected by Nirsum Laboratories to provide Contract Development and Manufacturing Organization services focused on supporting Nirsum’s clinical development of its lead development candidate, NRS-033. The activities to be conducted under the agreement include the assessment and technology transfer of the fill and finish process for NRS-033. These assessments will rely upon Lifecore’s differentiated expertise in the fill and finish of sterile injectable pharmaceutical products, potentially allowing Lifecore to create an overarching development and commercialization plan for the entire fill and finish process for NRS-033.